Park, Hyo K.
Schildkraut, Joellen M.
Alberg, Anthony J.
Bandera, Elisa V.
Barnholtz-Sloan, Jill S.
Bondy, Melissa
Crankshaw, Sydnee
Funkhouser, Ellen
Moorman, Patricia G.
Peters, Edward S.
Terry, Paul
Wang, Frances
Ruterbusch, Julie J.
Schwartz, Ann G.
Cote, Michele L.
Funding for this research was provided by:
National Cancer Institute (R01CA142081)
Article History
Received: 26 September 2017
Accepted: 17 September 2018
First Online: 29 September 2018
Compliance with ethical standards
:
: The study protocol and questionnaire were approved by the Institutional Review Boards at Duke University Medical Center, Baylor College of Medicine, Case Western Reserve University School of Medicine, Louisiana State University, Robert Wood Johnson Medical School/Rutgers Cancer Institute, Wayne State University, the University of Alabama-Birmingham, the Medical University of South Carolina, and the University of Tennessee-Knoxville. Additionally, the protocol was approved by central cancer registries in the states of Alabama, Georgia, North Carolina, South Carolina, Tennessee, and Texas, SEER registries in New Jersey, Louisiana, and the Detroit metropolitan area, and 9 individual hospital systems in Ohio. All study participants completed informed consent prior to enrollment.
: The dataset used and analyzed in this study is available after review from the AACES study investigators and with proper IRB approvals.
: The authors declare that they have no competing interests.